Is Abbott Laboratories Stock a Good Investment?

Abbott Laboratories Investment Advice

  ABT
To provide specific investment advice or recommendations on Abbott Laboratories stock, we recommend investors consider the following general factors when evaluating Abbott Laboratories. This will help you to make an informed decision on whether to include Abbott Laboratories in one of your diversified portfolios:
  • Examine Abbott Laboratories' financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
  • Research Abbott Laboratories' leadership team and their track record. Good management can help Abbott Laboratories navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
  • Consider the overall health of the Health Care Equipment & Supplies space and any emerging trends that could impact Abbott Laboratories' business and its evolving consumer preferences.
  • Compare Abbott Laboratories' performance and market position to its competitors. Analyze how Abbott Laboratories is positioned in terms of product offerings, innovation, and market share.
  • Check if Abbott Laboratories pays a dividend and its dividend yield and payout ratio.
  • Review what financial analysts are saying about Abbott Laboratories' stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Abbott Laboratories stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Abbott Laboratories is a good investment.
 
Sell
 
Buy
Buy
Macroaxis provides advice on Abbott Laboratories to complement and cross-verify current analyst consensus on Abbott Laboratories. Our investment recommendation engine determines the company's potential to grow exclusively from the perspective of an investor's current risk tolerance and investing horizon. To make sure Abbott Laboratories is not overpriced, please confirm all Abbott Laboratories fundamentals, including its current valuation, revenue, current ratio, as well as the relationship between the number of shares shorted and cash and equivalents . Given that Abbott Laboratories has a price to earning of 24.14 X, we suggest you to validate Abbott Laboratories market performance and probability of bankruptcy to ensure the company can sustain itself in the current economic cycle given your prevailing risk tolerance and investing horizon.

Market Performance

Very WeakDetails

Volatility

Very steadyDetails

Hype Condition

Low keyDetails

Current Valuation

Fairly ValuedDetails

Odds Of Distress

Very LowDetails

Economic Sensitivity

Moves indifferently to market movesDetails

Investor Sentiment

AlarmedDetails

Analyst Consensus

Strong BuyDetails

Financial Strenth (F Score)

StrongDetails

Financial Leverage

Not RatedDetails

Reporting Quality (M-Score)

Unlikely ManipulatorDetails

Examine Abbott Laboratories Stock

Researching Abbott Laboratories' stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 77.0% of the company shares are held by institutions such as insurance companies. The book value of Abbott Laboratories was presently reported as 22.26. The company last dividend was issued on the 12th of April 2024. Abbott Laboratories had 10000:4798 split on the 2nd of January 2013.
To determine if Abbott Laboratories is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Abbott Laboratories' research are outlined below:
Abbott Laboratories generated a negative expected return over the last 90 days
Abbott Laboratories has a strong financial position based on the latest SEC filings
Over 77.0% of the company shares are held by institutions such as insurance companies
Latest headline from marketbeat.com: Gemmer Asset Management LLC Top Holdings and 13F Report

Abbott Laboratories Quarterly Liabilities And Stockholders Equity

38.83 Billion

Abbott Laboratories uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Abbott Laboratories. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Abbott Laboratories' previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
17th of April 2024
Upcoming Quarterly Report
View
18th of July 2024
Next Financial Report
View
31st of March 2024
Next Fiscal Quarter End
View
22nd of January 2025
Next Fiscal Year End
View
31st of December 2023
Last Quarter Report
View
31st of December 2023
Last Financial Announcement
View
Earnings surprises can significantly impact Abbott Laboratories' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Abbott Laboratories' investors have experienced.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2017-04-19
2017-03-310.430.480.0511 
2015-04-22
2015-03-310.420.470.0511 
2014-04-16
2014-03-310.360.410.0513 
2020-04-16
2020-03-310.580.650.0712 
2023-01-25
2022-12-310.921.030.1111 
2021-07-22
2021-06-301.021.170.1514 
2020-07-16
2020-06-300.420.570.1535 
2022-10-19
2022-09-300.941.150.2122 

Abbott Laboratories Target Price Consensus

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Abbott target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Abbott Laboratories' target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
   25  Strong Buy
Most Abbott analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Abbott stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Abbott Laboratories, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice   Exposure   Valuation

Abbott Laboratories Target Price Projection

Abbott Laboratories' current and average target prices are 107.53 and 110.65, respectively. The current price of Abbott Laboratories is the price at which Abbott Laboratories is currently trading. On the other hand, Abbott Laboratories' target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.

Current Price

Abbott Laboratories Market Quote on 27th of April 2024

Low Price106.39Odds
High Price107.86Odds

107.53

Target Price

Analyst Consensus On Abbott Laboratories Target Price

Low Estimate100.69Odds
High Estimate122.82Odds

110.65

Historical Lowest Forecast  100.69 Target Price  110.65 Highest Forecast  122.82
Note that most analysts generally publish their price targets in research reports on specific companies, along with recommendations for the company's stock.Although price targets are often quoted in the financial news media, there could be a delay between the publication of the latest analyst outlook on Abbott Laboratories and the information provided on this page.

Abbott Laboratories Analyst Ratings

Abbott Laboratories' analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Abbott Laboratories stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Abbott Laboratories' financials, market performance, and future outlook by experienced professionals. Abbott Laboratories' historical ratings below, therefore, can serve as a valuable tool for investors.

Know Abbott Laboratories' Top Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Abbott Laboratories is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Abbott Laboratories backward and forwards among themselves. Abbott Laboratories' institutional investor refers to the entity that pools money to purchase Abbott Laboratories' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Wells Fargo & Co2023-12-31
16.5 M
Bank Of America Corp2023-12-31
16.4 M
Bank Of New York Mellon Corp2023-12-31
15.1 M
Legal & General Group Plc2023-12-31
14.3 M
State Farm Mutual Automobile Ins Co2023-12-31
13.6 M
Polen Capital2023-12-31
13.5 M
Jpmorgan Chase & Co2023-12-31
13.3 M
Hhg Plc2023-12-31
13.2 M
Nuveen Asset Management, Llc2023-12-31
12.4 M
Vanguard Group Inc2023-12-31
156.4 M
Blackrock Inc2023-12-31
134.1 M
Note, although Abbott Laboratories' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Abbott Laboratories' market capitalization trends

The company currently falls under 'Mega-Cap' category with a total capitalization of 185.47 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Abbott Laboratories's market, we take the total number of its shares issued and multiply it by Abbott Laboratories's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Market Cap

236.07 Billion

Abbott Laboratories' profitablity analysis

Abbott Laboratories' profitability indicators refer to fundamental financial ratios that showcase Abbott Laboratories' ability to generate income relative to its revenue or operating costs. If, let's say, Abbott Laboratories is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Abbott Laboratories' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Abbott Laboratories' profitability requires more research than a typical breakdown of Abbott Laboratories' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
Last ReportedProjected for Next Year
Return On Tangible Assets 0.14  0.17 
Return On Capital Employed 0.11  0.10 
Return On Assets 0.08  0.12 
Return On Equity 0.15  0.26 
The company has Net Profit Margin of 0.14 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.14 %, which entails that for every 100 dollars of revenue, it generated $0.14 of operating income.
Determining Abbott Laboratories' profitability involves analyzing its financial statements and using various financial metrics to determine if Abbott Laboratories is a good buy. For example, gross profit margin measures Abbott Laboratories' profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Abbott Laboratories' profitability and make more informed investment decisions.
The data published in Abbott Laboratories' official financial statements usually reflect Abbott Laboratories' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Abbott Laboratories. For example, before you start analyzing numbers published by Abbott accountants, it's critical to develop an understanding of what Abbott Laboratories' liquidity, profitability, and earnings quality are in the context of the Health Care Equipment & Supplies space in which it operates.
Please note, the presentation of Abbott Laboratories' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Abbott Laboratories' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Abbott Laboratories' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Abbott Laboratories. Please utilize our Beneish M Score to check the likelihood of Abbott Laboratories' management manipulating its earnings.

Evaluate Abbott Laboratories' management efficiency

Abbott Laboratories has Return on Asset of 0.0611 % which means that on every $100 spent on assets, it made $0.0611 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.1511 %, implying that it generated $0.1511 on every 100 dollars invested. Abbott Laboratories' management efficiency ratios could be used to measure how well Abbott Laboratories manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Abbott Laboratories' Return On Tangible Assets are comparatively stable compared to the past year. Return On Assets is likely to gain to 0.12 in 2024, whereas Return On Capital Employed is likely to drop 0.10 in 2024. At this time, Abbott Laboratories' Non Current Liabilities Other is comparatively stable compared to the past year. Change To Liabilities is likely to gain to about 44.7 M in 2024, whereas Total Current Liabilities is likely to drop slightly above 8.3 B in 2024.
Last ReportedProjected for Next Year
Book Value Per Share 22.19  23.29 
Net Current Asset Value 0.00  0.00 
Tangible Asset Value 0.00  0.00 
Tangible Book Value Per Share 3.64  3.82 
Enterprise Value Over EBITDA 18.94  19.89 
Price Book Value Ratio 4.96  2.62 
Enterprise Value Multiple 18.94  19.89 
Price Fair Value 4.96  2.62 
Enterprise Value233.1 B244.8 B
The analysis of Abbott Laboratories' management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze Abbott Laboratories' future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of Abbott Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Dividend Yield
0.0206
Forward Dividend Yield
0.0206
Forward Dividend Rate
2.2
Beta
0.74

Basic technical analysis of Abbott Stock

As of the 27th of April, Abbott Laboratories shows the risk adjusted performance of (0.04), and Mean Deviation of 0.9444. Abbott Laboratories technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We have analyzed thirteen technical drivers for Abbott Laboratories, which can be compared to its peers. Please confirm Abbott Laboratories standard deviation, as well as the relationship between the maximum drawdown and kurtosis to decide if Abbott Laboratories is priced correctly, providing market reflects its regular price of 107.53 per share. Given that Abbott Laboratories has information ratio of (0.14), we suggest you to validate Abbott Laboratories's prevailing market performance to make sure the company can sustain itself at a future point.

Abbott Laboratories' Outstanding Corporate Bonds

Abbott Laboratories issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Abbott Laboratories uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Abbott bonds can be classified according to their maturity, which is the date when Abbott Laboratories has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Understand Abbott Laboratories' technical and predictive indicators

Using predictive indicators to make investment decisions involves analyzing Abbott Laboratories' various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.

Consider Abbott Laboratories' intraday indicators

Abbott Laboratories intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Abbott Laboratories stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Abbott Laboratories Corporate Filings

8K
17th of April 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
F4
2nd of April 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
15th of March 2024
Other Reports
ViewVerify
10K
16th of February 2024
Annual report required by the U.S. Securities and Exchange Commission (SEC) of a company financial performance
ViewVerify
Abbott Laboratories time-series forecasting models is one of many Abbott Laboratories' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Abbott Laboratories' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Abbott Stock media impact

Far too much social signal, news, headlines, and media speculation about Abbott Laboratories that are available to investors today. That information is available publicly through Abbott media outlets and privately through word of mouth or via Abbott internal channels. However, regardless of the origin, that massive amount of Abbott data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Abbott Laboratories news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Abbott Laboratories relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Abbott Laboratories' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Abbott Laboratories alpha.

Abbott Laboratories Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Abbott Laboratories can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Abbott Laboratories Historical Investor Sentiment

Investor biases related to Abbott Laboratories' public news can be used to forecast risks associated with an investment in Abbott. The trend in average sentiment can be used to explain how an investor holding Abbott can time the market purely based on public headlines and social activities around Abbott Laboratories. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Abbott Laboratories' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Abbott Laboratories and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Abbott Laboratories news discussions. The higher the estimate score, the more favorable the investor's outlook on Abbott Laboratories.

Abbott Laboratories Maximum Pain Price across 2024-04-26 Option Contracts

Abbott Laboratories' options can also be used to analyze investors' bias and current market sentiment in the context of behavioral finance. For example, Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of Abbott Laboratories close to the expiration of its current option contract to expire worthlessly. According to most research, about 35% of options are not executed, with roughly 50% traded out before expiration. So, Max pain occurs when market makers reach a net favorable position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthlessly. Please continue to view the detailed analysis of Abbott Laboratories' options.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Abbott Laboratories without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Portfolio Suggestion Now

   

Portfolio Suggestion

Get suggestions outside of your existing asset allocation including your own model portfolios
All  Next Launch Module

Abbott Laboratories Corporate Directors

Abbott Laboratories corporate directors refer to members of an Abbott Laboratories board of directors. The board of directors generally takes responsibility for the Abbott Laboratories' affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Abbott Laboratories' board members must vote for the resolution. The Abbott Laboratories board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Samuel ScottIndependent DirectorProfile
James FarrellIndependent DirectorProfile
Phebe NovakovicIndependent DirectorProfile
Roxanne AustinIndependent DirectorProfile

How to buy Abbott Stock?

To provide specific investment advice or recommendations on Abbott Laboratories stock, we recommend investors consider the following general factors when evaluating Abbott Laboratories. This will help you to make an informed decision on whether to include Abbott Laboratories in one of your diversified portfolios:
  • Examine Abbott Laboratories' financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
  • Research Abbott Laboratories' leadership team and their track record. Good management can help Abbott Laboratories navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
  • Consider the overall health of the Health Care Equipment & Supplies space and any emerging trends that could impact Abbott Laboratories' business and its evolving consumer preferences.
  • Compare Abbott Laboratories' performance and market position to its competitors. Analyze how Abbott Laboratories is positioned in terms of product offerings, innovation, and market share.
  • Check if Abbott Laboratories pays a dividend and its dividend yield and payout ratio.
  • Review what financial analysts are saying about Abbott Laboratories' stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Abbott Laboratories stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Abbott Laboratories is a good investment.

Already Invested in Abbott Laboratories?

The danger of trading Abbott Laboratories is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Abbott Laboratories is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Abbott Laboratories. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Abbott Laboratories is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Abbott Laboratories is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Abbott Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Abbott Laboratories Stock. Highlighted below are key reports to facilitate an investment decision about Abbott Laboratories Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Abbott Laboratories. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics.
For more information on how to buy Abbott Stock please use our How to Invest in Abbott Laboratories guide.
Note that the Abbott Laboratories information on this page should be used as a complementary analysis to other Abbott Laboratories' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Complementary Tools for Abbott Stock analysis

When running Abbott Laboratories' price analysis, check to measure Abbott Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abbott Laboratories is operating at the current time. Most of Abbott Laboratories' value examination focuses on studying past and present price action to predict the probability of Abbott Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abbott Laboratories' price. Additionally, you may evaluate how the addition of Abbott Laboratories to your portfolios can decrease your overall portfolio volatility.
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
CEOs Directory
Screen CEOs from public companies around the world
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Stocks Directory
Find actively traded stocks across global markets
Commodity Directory
Find actively traded commodities issued by global exchanges
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Bonds Directory
Find actively traded corporate debentures issued by US companies
Is Abbott Laboratories' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Abbott Laboratories. If investors know Abbott will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Abbott Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.07)
Dividend Share
2.12
Earnings Share
3.21
Revenue Per Share
23.183
Quarterly Revenue Growth
0.022
The market value of Abbott Laboratories is measured differently than its book value, which is the value of Abbott that is recorded on the company's balance sheet. Investors also form their own opinion of Abbott Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Abbott Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Abbott Laboratories' market value can be influenced by many factors that don't directly affect Abbott Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between Abbott Laboratories' value and its price, as these two are different measures arrived at by various means. Investors typically determine if Abbott Laboratories is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Abbott Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.